Pfizer (PFE) is in talks to acquire rival Wyeth (WYE) in a deal that could be worth over $60B....

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (PFE) is in talks to acquire rival Wyeth (WYE) in a deal that could be worth over $60B. An acquisition would create a drug giant with combined revenue of around $75B and a strong line of blockbuster drugs. Sources say a deal is not yet imminent.